Pulmovant
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
303 Wyman St Ste 300, Waltham, Massachus...Website
www.pulmovant.comRevenue
$8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Pulmovant
Pulmovant is dedicated to transforming the treatment paradigm for patients with pulmonary diseases through innovative therapies, beginning with mosliciguat. This once-daily, inhaled treatment aims to provide an effective option for those suffering from pulmonary diseases. The company is focused on the unique needs of these patients and strives to deliver significant benefits through its first-in-class sGC activation mechanism. Pulmovant is committed to advancing its science and conducting clinical trials to support its mission.Explore more
Pulmovant Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pulmovant your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Pulmovant recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Pulmovant had a recent Job posting/layoffs
Pulmovant, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Pulmovant has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Pulmovant has new funding data
Check out if Pulmovant is spiking on competitors!
Product Launch: Get notified when Pulmovant launches new products
Congratulate Masked Content for being promoted to Masked Content at Pulmovant
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Pulmovant is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pulmovant is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pulmovant.
Pulmovant Tech Stack
A closer look at the technologies used by Pulmovant
Most Recent Scoops
Open Position
Promotion
Executive Move
Jennifer Cormier has recently been promoted from Senior Vice President, Clinical Operations to the role of Chief Development Operations Officer.
Executive Moves, Promotion
Promotion
Executive Move
Carlos Sanmarco has recently been promoted from Senior Vice President, Program Leadership & Operations to the role of Chief Operating Officer.
Executive Moves, Promotion
Open Position
Open Position
Pulmovant News & Media
Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
WALTHAM, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Pulmovant, a clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases, and a Roivant (Nasdaq: ROIV) company, today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to mosliciguat, a novel, once-daily, inhaled soluble guanylate cyclase (sGC) activator, currently being studied for the treatment of Pulmonary Hypertension associated with
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pulmovant
Sign Up For FreeTo access detailed company insights
Pulmovant is dedicated to transforming the treatment paradigm for patients with pulmonary diseases through innovative therapies, beginning with mosliciguat. This once-daily, inhaled treatment aims to provide an effective option for those suffering from pulmonary diseases. The company is focused on the unique needs of these patients and strives to d... Read More
